0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-27H11910
Home | Market Reports | Health| Aging & Geriatrics
Global Alzheimer s Disease Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-27H11910
Report
September 2022
100 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Alzheimer's Disease Drug market is projected to reach US$ 4020.5 million by 2028 from an estimated US$ 3676.9 million in 2022, at a CAGR of 1.5% during 2023 and 2028.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug.
The Alzheimer's Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Alzheimer's Disease Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Product Type Insights
Global markets are presented by Alzheimer's Disease Drug type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Alzheimer's Disease Drug are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Alzheimer's Disease Drug Segment by Type

Donepezil
Memantine
Rivastigmine
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Alzheimer's Disease Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Alzheimer's Disease Drug market.

Alzheimer's Disease Drug Segment by Application

Early to Moderate Stages
Moderate to Severe Stages
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Alzheimer's Disease Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alzheimer's Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Alzheimer's Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Alzheimer's Disease Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alzheimer's Disease Drug

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Alzheimer's Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts
2.1.1 Global Alzheimer's Disease Drug Revenue 2017-2028
2.1.2 Global Alzheimer's Disease Drug Sales 2017-2028
2.2 Alzheimer's Disease Drug Market Size by Region: 2022 Versus 2028
2.3 Alzheimer's Disease Drug Sales by Region (2017-2028)
2.3.1 Global Alzheimer's Disease Drug Sales by Region: 2017-2022
2.3.2 Global Alzheimer's Disease Drug Sales Forecast by Region (2023-2028)
2.3.3 Global Alzheimer's Disease Drug Sales Market Share by Region (2017-2028)
2.4 Alzheimer's Disease Drug Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Alzheimer's Disease Drug Revenue by Region: 2017-2022
2.4.2 Global Alzheimer's Disease Drug Revenue Forecast by Region (2023-2028)
2.4.3 Global Alzheimer's Disease Drug Revenue Market Share by Region (2017-2028)
3 Global Alzheimer's Disease Drug by Manufacturers
3.1 Global Top Alzheimer's Disease Drug Manufacturers by Sales
3.1.1 Global Alzheimer's Disease Drug Sales by Manufacturer (2017-2022)
3.1.2 Global Alzheimer's Disease Drug Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Alzheimer's Disease Drug Manufacturers by Revenue
3.2.1 Global Alzheimer's Disease Drug Revenue by Manufacturer (2017-2022)
3.2.2 Global Alzheimer's Disease Drug Revenue Share by Manufacturer (2017-2022)
3.3 Global Alzheimer's Disease Drug Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Alzheimer's Disease Drug Manufacturers Covered: Ranking by Revenue
3.4.2 Global Alzheimer's Disease Drug Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Alzheimer's Disease Drug Manufacturing Base Distribution, Product Type
3.5.1 Alzheimer's Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Alzheimer's Disease Drug Product Type
3.5.3 Date of International Manufacturers Enter into Alzheimer's Disease Drug Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Allergan
4.1.1 Allergan Corporation Information
4.1.2 Allergan Description, Business Overview
4.1.3 Allergan Alzheimer's Disease Drug Products Offered
4.1.4 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Allergan Alzheimer's Disease Drug Sales by Product in 2021
4.1.6 Allergan Alzheimer's Disease Drug Sales by Application in 2021
4.1.7 Allergan Alzheimer's Disease Drug Sales by Geographic Area in 2021
4.1.8 Allergan Recent Developments
4.2 Eisai
4.2.1 Eisai Corporation Information
4.2.2 Eisai Description, Business Overview
4.2.3 Eisai Alzheimer's Disease Drug Products Offered
4.2.4 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Eisai Alzheimer's Disease Drug Sales by Product in 2021
4.2.6 Eisai Alzheimer's Disease Drug Sales by Application in 2021
4.2.7 Eisai Alzheimer's Disease Drug Sales by Geographic Area in 2021
4.2.8 Eisai Recent Developments
4.3 Novartis
4.3.1 Novartis Corporation Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Alzheimer's Disease Drug Products Offered
4.3.4 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Novartis Alzheimer's Disease Drug Sales by Product in 2021
4.3.6 Novartis Alzheimer's Disease Drug Sales by Application in 2021
4.3.7 Novartis Alzheimer's Disease Drug Sales by Geographic Area in 2021
4.3.8 Novartis Recent Developments
4.4 Daiichi Sankyo
4.4.1 Daiichi Sankyo Corporation Information
4.4.2 Daiichi Sankyo Description, Business Overview
4.4.3 Daiichi Sankyo Alzheimer's Disease Drug Products Offered
4.4.4 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Daiichi Sankyo Alzheimer's Disease Drug Sales by Product in 2021
4.4.6 Daiichi Sankyo Alzheimer's Disease Drug Sales by Application in 2021
4.4.7 Daiichi Sankyo Alzheimer's Disease Drug Sales by Geographic Area in 2021
4.4.8 Daiichi Sankyo Recent Developments
4.5 Merz Pharma
4.5.1 Merz Pharma Corporation Information
4.5.2 Merz Pharma Description, Business Overview
4.5.3 Merz Pharma Alzheimer's Disease Drug Products Offered
4.5.4 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Merz Pharma Alzheimer's Disease Drug Sales by Product in 2021
4.5.6 Merz Pharma Alzheimer's Disease Drug Sales by Application in 2021
4.5.7 Merz Pharma Alzheimer's Disease Drug Sales by Geographic Area in 2021
4.5.8 Merz Pharma Recent Developments
4.6 Pfizer
4.6.1 Pfizer Corporation Information
4.6.2 Pfizer Description, Business Overview
4.6.3 Pfizer Alzheimer's Disease Drug Products Offered
4.6.4 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Pfizer Alzheimer's Disease Drug Sales by Product in 2021
4.6.6 Pfizer Alzheimer's Disease Drug Sales by Application in 2021
4.6.7 Pfizer Alzheimer's Disease Drug Sales by Geographic Area in 2021
4.6.8 Pfizer Recent Development
4.7 Johnson & Johnson
4.7.1 Johnson & Johnson Corporation Information
4.7.2 Johnson & Johnson Description, Business Overview
4.7.3 Johnson & Johnson Alzheimer's Disease Drug Products Offered
4.7.4 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Johnson & Johnson Alzheimer's Disease Drug Sales by Product in 2021
4.7.6 Johnson & Johnson Alzheimer's Disease Drug Sales by Application in 2021
4.7.7 Johnson & Johnson Alzheimer's Disease Drug Sales by Geographic Area in 2021
4.7.8 Johnson & Johnson Recent Development
4.8 Lundbeck
4.8.1 Lundbeck Corporation Information
4.8.2 Lundbeck Description, Business Overview
4.8.3 Lundbeck Alzheimer's Disease Drug Products Offered
4.8.4 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Lundbeck Alzheimer's Disease Drug Sales by Product in 2021
4.8.6 Lundbeck Alzheimer's Disease Drug Sales by Application in 2021
4.8.7 Lundbeck Alzheimer's Disease Drug Sales by Geographic Area in 2021
4.8.8 Lundbeck Recent Development
5 Breakdown Data by Type
5.1 Global Alzheimer's Disease Drug Sales by Type (2017-2028)
5.1.1 Global Alzheimer's Disease Drug Sales by Type (2017-2022)
5.1.2 Global Alzheimer's Disease Drug Sales Forecast by Type (2023-2028)
5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2017-2028)
5.2 Global Alzheimer's Disease Drug Revenue Forecast by Type (2017-2028)
5.2.1 Global Alzheimer's Disease Drug Revenue by Type (2017-2022)
5.2.2 Global Alzheimer's Disease Drug Revenue Forecast by Type (2023-2028)
5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2017-2028)
5.3 Alzheimer's Disease Drug Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Alzheimer's Disease Drug Sales by Application (2017-2028)
6.1.1 Global Alzheimer's Disease Drug Sales by Application (2017-2022)
6.1.2 Global Alzheimer's Disease Drug Sales Forecast by Application (2023-2028)
6.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2017-2028)
6.2 Global Alzheimer's Disease Drug Revenue Forecast by Application (2017-2028)
6.2.1 Global Alzheimer's Disease Drug Revenue by Application (2017-2022)
6.2.2 Global Alzheimer's Disease Drug Revenue Forecast by Application (2023-2028)
6.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2017-2028)
6.3 Alzheimer's Disease Drug Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
7.2 North America Alzheimer's Disease Drug Market Facts & Figures by Country
7.2.1 North America Alzheimer's Disease Drug Sales by Country (2017-2028)
7.2.2 North America Alzheimer's Disease Drug Revenue by Country (2017-2028)
7.3 North America Alzheimer's Disease Drug Sales by Type
7.4 North America Alzheimer's Disease Drug Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Alzheimer's Disease Drug Market Facts & Figures by Region
8.2.1 Asia-Pacific Alzheimer's Disease Drug Sales by Region (2017-2028)
8.2.2 Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2017-2028)
8.3 Asia-Pacific Alzheimer's Disease Drug Sales by Type
8.4 Asia-Pacific Alzheimer's Disease Drug Sales by Application
9 Europe
9.1 Europe Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
9.2 Europe Alzheimer's Disease Drug Market Facts & Figures by Country
9.2.1 Europe Alzheimer's Disease Drug Sales by Country (2017-2028)
9.2.2 Europe Alzheimer's Disease Drug Revenue by Country (2017-2028)
9.3 Europe Alzheimer's Disease Drug Sales by Type
9.4 Europe Alzheimer's Disease Drug Sales by Application
10 Latin America
10.1 Latin America Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
10.2 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country
10.2.1 Latin America Alzheimer's Disease Drug Sales by Country (2017-2028)
10.2.2 Latin America Alzheimer's Disease Drug Revenue by Country (2017-2028)
10.3 Latin America Alzheimer's Disease Drug Sales by Type
10.4 Latin America Alzheimer's Disease Drug Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2017-2028)
11.2.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2017-2028)
11.3 Middle East and Africa Alzheimer's Disease Drug Sales by Type
11.4 Middle East and Africa Alzheimer's Disease Drug Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Alzheimer's Disease Drug Supply Chain Analysis
12.2 Alzheimer's Disease Drug Key Raw Materials and Upstream Suppliers
12.3 Alzheimer's Disease Drug Clients Analysis
12.4 Alzheimer's Disease Drug Sales Channel and Sales Model Analysis
12.4.1 Alzheimer's Disease Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Alzheimer's Disease Drug Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Alzheimer's Disease Drug Distributors
13 Market Dynamics
13.1 Alzheimer's Disease Drug Industry Trends
13.2 Alzheimer's Disease Drug Market Drivers
13.3 Alzheimer's Disease Drug Market Challenges
13.4 Alzheimer's Disease Drug Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Alzheimer's Disease Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Donepezil
    Table 3. Major Manufacturers of Memantine
    Table 4. Major Manufacturers of Rivastigmine
    Table 5. Major Manufacturers of Others
    Table 6. Global Alzheimer's Disease Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 8. Global Alzheimer's Disease Drug Sales by Region (2017-2022) & (K Units)
    Table 9. Global Alzheimer's Disease Drug Sales Forecast by Region (2023-2028) & (K Units)
    Table 10. Global Alzheimer's Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Alzheimer's Disease Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 12. Global Alzheimer's Disease Drug Sales by Manufacturer (2017-2022) & (K Units)
    Table 13. Global Alzheimer's Disease Drug Sales Share by Manufacturer (2017-2022)
    Table 14. Alzheimer's Disease Drug Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 15. Alzheimer's Disease Drug Revenue Share by Manufacturer (2017-2022)
    Table 16. Key Manufacturers Alzheimer's Disease Drug Price (2017-2022) & (USD/Unit)
    Table 17. Ranking of Global Top Alzheimer's Disease Drug Manufacturers by Revenue (US$ Million) in 2021
    Table 18. Global Alzheimer's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 19. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2021)
    Table 20. Alzheimer's Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
    Table 21. Manufacturers Alzheimer's Disease Drug Product Type
    Table 22. Date of International Manufacturers Enter into Alzheimer's Disease Drug Market
    Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 24. Allergan Corporation Information
    Table 25. Allergan Description and Business Overview
    Table 26. Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 27. Allergan Alzheimer's Disease Drug Product
    Table 28. Allergan Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Product in 2021
    Table 29. Allergan Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Application in 2021
    Table 30. Allergan Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2021
    Table 31. Allergan Recent Development
    Table 32. Eisai Corporation Information
    Table 33. Eisai Description and Business Overview
    Table 34. Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 35. Eisai Alzheimer's Disease Drug Product
    Table 36. Eisai Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Product in 2021
    Table 37. Eisai Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Application in 2021
    Table 38. Eisai Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2021
    Table 39. Eisai Recent Development
    Table 40. Novartis Corporation Information
    Table 41. Novartis Description and Business Overview
    Table 42. Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 43. Novartis Alzheimer's Disease Drug Product
    Table 44. Novartis Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Product in 2021
    Table 45. Novartis Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Application in 2021
    Table 46. Novartis Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2021
    Table 47. Novartis Recent Development
    Table 48. Daiichi Sankyo Corporation Information
    Table 49. Daiichi Sankyo Description and Business Overview
    Table 50. Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 51. Daiichi Sankyo Alzheimer's Disease Drug Product
    Table 52. Daiichi Sankyo Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Product in 2021
    Table 53. Daiichi Sankyo Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Application in 2021
    Table 54. Daiichi Sankyo Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2021
    Table 55. Daiichi Sankyo Recent Development
    Table 56. Merz Pharma Corporation Information
    Table 57. Merz Pharma Description and Business Overview
    Table 58. Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 59. Merz Pharma Alzheimer's Disease Drug Product
    Table 60. Merz Pharma Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Product in 2021
    Table 61. Merz Pharma Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Application in 2021
    Table 62. Merz Pharma Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2021
    Table 63. Merz Pharma Recent Development
    Table 64. Pfizer Corporation Information
    Table 65. Pfizer Description and Business Overview
    Table 66. Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Pfizer Alzheimer's Disease Drug Product
    Table 68. Pfizer Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Product in 2021
    Table 69. Pfizer Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Application in 2021
    Table 70. Pfizer Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2021
    Table 71. Johnson & Johnson Corporation Information
    Table 72. Johnson & Johnson Description and Business Overview
    Table 73. Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 74. Johnson & Johnson Alzheimer's Disease Drug Product
    Table 75. Johnson & Johnson Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Product in 2021
    Table 76. Johnson & Johnson Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Application in 2021
    Table 77. Johnson & Johnson Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2021
    Table 78. Lundbeck Corporation Information
    Table 79. Lundbeck Description and Business Overview
    Table 80. Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 81. Lundbeck Alzheimer's Disease Drug Product
    Table 82. Lundbeck Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Product in 2021
    Table 83. Lundbeck Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Application in 2021
    Table 84. Lundbeck Alzheimer's Disease Drug Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2021
    Table 85. Global Alzheimer's Disease Drug Sales by Type (2017-2022) & (K Units)
    Table 86. Global Alzheimer's Disease Drug Sales Forecast by Type (2023-2028) & (K Units)
    Table 87. Global Alzheimer's Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Global Alzheimer's Disease Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 89. Global Alzheimer's Disease Drug Sales by Application (2017-2022) & (K Units)
    Table 90. Global Alzheimer's Disease Drug Sales Forecast by Application (2023-2028) & (K Units)
    Table 91. Global Alzheimer's Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Global Alzheimer's Disease Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 93. North America Alzheimer's Disease Drug Sales by Country (2017-2022) & (K Units)
    Table 94. North America Alzheimer's Disease Drug Sales by Country (2023-2028) & (K Units)
    Table 95. North America Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 96. North America Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 97. North America Alzheimer's Disease Drug Sales by Type (2017-2022) & (K Units)
    Table 98. North America Alzheimer's Disease Drug Sales by Application (2017-2022) & (K Units)
    Table 99. Asia-Pacific Alzheimer's Disease Drug Sales by Region (2017-2022) & (K Units)
    Table 100. Asia-Pacific Alzheimer's Disease Drug Sales by Region (2023-2028) & (K Units)
    Table 101. Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2017-2028) & (US$ Million)
    Table 102. Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 103. Asia-Pacific Alzheimer's Disease Drug Sales by Type (2017-2022) & (K Units)
    Table 104. Asia-Pacific Alzheimer's Disease Drug Sales by Application (2017-2022) & (K Units)
    Table 105. Europe Alzheimer's Disease Drug Sales by Country (2017-2022) & (K Units)
    Table 106. Europe Alzheimer's Disease Drug Sales by Country (2023-2028) & (K Units)
    Table 107. Europe Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Europe Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Europe Alzheimer's Disease Drug Sales by Type (2017-2022) & (K Units)
    Table 110. Europe Alzheimer's Disease Drug Sales by Application (2017-2022) & (K Units)
    Table 111. Latin America Alzheimer's Disease Drug Sales by Country (2017-2022) & (K Units)
    Table 112. Latin America Alzheimer's Disease Drug Sales by Country (2023-2028) & (K Units)
    Table 113. Latin America Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 114. Latin America Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 115. Latin America Alzheimer's Disease Drug Sales by Type (2017-2022) & (K Units)
    Table 116. Latin America Alzheimer's Disease Drug Sales by Application (2017-2022) & (K Units)
    Table 117. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2017-2022) & (K Units)
    Table 118. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2023-2028) & (K Units)
    Table 119. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 120. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 121. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2017-2022) & (K Units)
    Table 122. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2017-2022) & (K Units)
    Table 123. Alzheimer's Disease Drug Key Raw Materials, Industry Status and Trend
    Table 124. Alzheimer's Disease Drug Key Raw Materials and Upstream Suppliers
    Table 125. Alzheimer's Disease Drug Clients Status and Trend
    Table 126. Alzheimer's Disease Drug Typical Clients
    Table 127. Alzheimer's Disease Drug Distributors
    Table 128. Alzheimer's Disease Drug Market Trends
    Table 129. Alzheimer's Disease Drug Market Drivers
    Table 130. Alzheimer's Disease Drug Market Challenges
    Table 131. Alzheimer's Disease Drug Market Restraints
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alzheimer's Disease Drug Product Picture
    Figure 2. Global Alzheimer's Disease Drug Sales Market Share by Type in 2021 & 2028
    Figure 3. Donepezil Product Picture
    Figure 4. Memantine Product Picture
    Figure 5. Rivastigmine Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Alzheimer's Disease Drug Sales Market Share by Application in 2021 & 2028
    Figure 8. Early to Moderate Stages Examples
    Figure 9. Moderate to Severe Stages Examples
    Figure 10. Alzheimer's Disease Drug Report Years Considered
    Figure 11. Global Alzheimer's Disease Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Alzheimer's Disease Drug Market Size 2017-2028 (US$ Million)
    Figure 13. Global Alzheimer's Disease Drug Sales 2017-2028 (K Units)
    Figure 14. Global Alzheimer's Disease Drug Market Size Market Share by Region: 2022 Versus 2028
    Figure 15. Global Alzheimer's Disease Drug Sales Market Share Forecast by Region (2017-2028)
    Figure 16. Global Alzheimer's Disease Drug Revenue Market Share by Region (2017-2028)
    Figure 17. Global Alzheimer's Disease Drug Sales Share by Manufacturer in 2021
    Figure 18. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Alzheimer's Disease Drug Sales Market Share Forecast by Type (2017-2028)
    Figure 20. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Type (2017-2028)
    Figure 21. Alzheimer's Disease Drug Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
    Figure 22. Global Alzheimer's Disease Drug Sales Market Share Forecast by Application (2017-2028)
    Figure 23. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Application (2017-2028)
    Figure 24. Alzheimer's Disease Drug Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
    Figure 25. North America Alzheimer's Disease Drug Revenue 2017-2028 (US$ Million)
    Figure 26. North America Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
    Figure 27. North America Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
    Figure 28. Asia-Pacific Alzheimer's Disease Drug Revenue 2017-2028 (US$ Million)
    Figure 29. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Region (2017-2028)
    Figure 30. Asia-Pacific Alzheimer's Disease Drug Revenue Market Share by Region (2017-2028)
    Figure 31. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
    Figure 32. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
    Figure 33. Europe Alzheimer's Disease Drug Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 34. Europe Alzheimer's Disease Drug Sales Market Share by Country (2017-2028)
    Figure 35. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2017-2028)
    Figure 36. Europe Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
    Figure 37. Europe Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
    Figure 38. Latin America Alzheimer's Disease Drug Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 39. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2017-2028)
    Figure 40. Latin America Alzheimer's Disease Drug Revenue Market Share by Country (2017-2022)
    Figure 41. Latin America Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
    Figure 42. Latin America Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
    Figure 43. Middle East and Africa Alzheimer's Disease Drug Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 44. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Country (2017-2028)
    Figure 45. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Country (2017-2028)
    Figure 46. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
    Figure 47. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
    Figure 48. Alzheimer's Disease Drug Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Alzheimer's Disease Drug Raw Materials by Region in 2021
    Figure 50. Alzheimer's Disease Drug Distribution Channels
    Figure 51. Global Alzheimer's Disease Drug Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 52. Global Alzheimer's Disease Drug Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD
SIMILAR REPORTS